4 March 2011
New research has shown that Ibuprofen could have a protective effect against the development of Parkinson's.
Published in the journal Neurology, the US study shows that regular Ibuprofen users are 40 per cent less likely to develop Parkinson's disease than people who do not take the drug.
However, the researchers behind the preliminary investigation have warned consumers that it is too early to tell if the benefits of taking the drug outweigh the potentially dangerous side effects of habitual use - including an increased risk of gastrointestinal bleeding.
Professor Alberto Ascherio, lead research from the Harvard School of Public Health, said: "There is no cure for Parkinson's disease, so the possibility that ibuprofen, an existing and relatively non-toxic drug, could help protect against the disease is captivating."
The research, which was funded by the Michael J Fox Foundation, compared the benefits of regular Ibuprofen use compared to other non-steroidal anti-inflammatory drugs - such as aspirin - which seemed to have no effect on the incidence of Parkinson's.
Meanwhile, Dr Kieran Breen, director of research and development at Parkinson's UK, claimed that the University of Oxford is funding similar research in Britain.
1 Ascherio, Alberto et al. "Use of ibuprofen and risk of Parkinson disease". Neurology. Tuesday, March 2nd 2011.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.